GENSIGHT BIOLOGICS

GenSight Biologics S.A. is a clinical-stage biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders... Our gene therapy-based approach appeals to us not just because we are excited about bringing advanced, innovative science to bear on diseases with a severe impact on patients' quality of life. Our approach also energizes us because it holds out the promise of a long-lasting cure administered in a manner that is simple and convenient for patients and their physicians. Thus, our two leading product candidates are currently designed to be administered in a single treatment to each eye by intravitreal, or IVT, injection... We are a gene therapy company seeking to apply pathbreaking science to help patients with severe inherited diseases of the eye and central nervous system.

Also known as: GENSIGHT BIOLOGICS Inc., GenSight Biologics S.A.

Primary location: Paris France